BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,765 | -23.6% | 46,784 | -7.8% | 0.05% | -12.3% |
| Q2 2023 | $2,311 | -13.7% | 50,741 | -23.2% | 0.06% | +1.8% |
| Q1 2023 | $2,679 | -37.1% | 66,072 | -20.9% | 0.06% | -25.3% |
| Q4 2022 | $4,260 | -99.9% | 83,581 | 0.0% | 0.08% | -11.8% |
| Q3 2022 | $4,501,000 | -18.2% | 83,581 | 0.0% | 0.08% | -13.3% |
| Q2 2022 | $5,500,000 | -15.1% | 83,581 | 0.0% | 0.10% | +1.0% |
| Q1 2022 | $6,480,000 | -9.7% | 83,581 | 0.0% | 0.10% | -4.0% |
| Q4 2021 | $7,174,000 | -11.1% | 83,581 | -16.7% | 0.10% | -2.9% |
| Q3 2021 | $8,073,000 | -1.0% | 100,376 | -0.9% | 0.10% | +1.0% |
| Q2 2021 | $8,152,000 | -5.4% | 101,278 | -0.9% | 0.10% | -12.7% |
| Q1 2021 | $8,617,000 | -6.4% | 102,173 | -10.9% | 0.12% | -2.5% |
| Q4 2020 | $9,205,000 | -6.7% | 114,719 | -6.5% | 0.12% | -12.9% |
| Q3 2020 | $9,870,000 | -7.2% | 122,732 | -0.6% | 0.14% | -14.7% |
| Q2 2020 | $10,634,000 | +12.8% | 123,512 | +6.4% | 0.16% | -8.4% |
| Q1 2020 | $9,425,000 | -3.1% | 116,087 | -0.2% | 0.18% | +20.3% |
| Q4 2019 | $9,725,000 | -4.3% | 116,302 | +0.1% | 0.15% | -12.4% |
| Q3 2019 | $10,161,000 | +6.0% | 116,172 | -0.8% | 0.17% | +5.6% |
| Q2 2019 | $9,590,000 | +0.0% | 117,106 | -0.7% | 0.16% | -4.2% |
| Q1 2019 | $9,588,000 | +23.8% | 117,923 | +0.2% | 0.17% | +9.2% |
| Q4 2018 | $7,745,000 | -40.3% | 117,670 | -30.1% | 0.15% | 0.0% |
| Q3 2018 | $12,972,000 | +7.1% | 168,277 | +2.5% | 0.15% | +0.7% |
| Q2 2018 | $12,117,000 | +21.0% | 164,102 | +6.6% | 0.15% | +16.9% |
| Q1 2018 | $10,012,000 | +0.4% | 153,942 | -0.3% | 0.13% | +2.4% |
| Q4 2017 | $9,976,000 | +4.7% | 154,342 | +1.6% | 0.13% | -0.8% |
| Q3 2017 | $9,528,000 | +3.7% | 151,842 | 0.0% | 0.13% | -1.5% |
| Q2 2017 | $9,192,000 | +13.2% | 151,842 | -3.1% | 0.13% | +9.2% |
| Q1 2017 | $8,123,000 | +20.3% | 156,642 | +2.9% | 0.12% | +15.5% |
| Q4 2016 | $6,750,000 | -6.5% | 152,242 | +0.3% | 0.10% | -12.0% |
| Q3 2016 | $7,222,000 | +5.3% | 151,742 | 0.0% | 0.12% | +1.7% |
| Q2 2016 | $6,861,000 | +3.2% | 151,742 | -6.2% | 0.12% | +2.7% |
| Q1 2016 | $6,648,000 | +9.4% | 161,842 | +1.6% | 0.11% | +6.7% |
| Q4 2015 | $6,077,000 | +19.4% | 159,292 | +2.8% | 0.10% | +9.4% |
| Q3 2015 | $5,089,000 | -52.9% | 154,912 | +0.3% | 0.10% | -48.9% |
| Q2 2015 | $10,798,000 | +2.3% | 154,412 | +0.2% | 0.19% | 0.0% |
| Q1 2015 | $10,553,000 | -6.5% | 154,052 | 0.0% | 0.19% | -6.0% |
| Q4 2014 | $11,290,000 | +3.7% | 154,052 | +1.6% | 0.20% | -0.5% |
| Q3 2014 | $10,884,000 | -0.7% | 151,652 | 0.0% | 0.20% | -0.5% |
| Q2 2014 | $10,964,000 | -1.7% | 151,652 | 0.0% | 0.20% | -7.3% |
| Q1 2014 | $11,159,000 | +5.8% | 151,652 | 0.0% | 0.22% | +3.8% |
| Q4 2013 | $10,547,000 | – | 151,652 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |